Wednesday, April 18, 2007

Multiple sclerosis: novel therapies set to increase market value
Pharmaceutical Business Review - USA
Only two candidates are targeting underserved
primary progressive
and secondary progressive
patients in the current late stage pipeline, namely Biogen ...
See all stories on this topic

CoHo neighbors raise funds
Corvallis Gazette Times - Corvallis,OR,USA
Volpe said he didn’t realize at first how dealing with
primary progressive multiple sclerosis

changed the way he interacted, or didn’t, with others. ...
See all stories on this topic

0 Comments:

Post a Comment

<< Home